Tinelli C - Search Results

1

Haemostatic activation in HIV infected patients treated with different antiretroviral regimens.

Pan A, Testa S, Quiros Roldan E, Tinelli C, Bodini U, Cadeo B, Carnevale G, Martinelli I, Maserati R, Morstabilini P, Seminari E, Signorini L, Carosi G. Pan A, et al. Among authors: tinelli c. Curr HIV Res. 2008 Jan;6(1):70-6. doi: 10.2174/157016208783571928. Curr HIV Res. 2008. PMID: 18288978

2

Hepatitis C infection on immune recovery in HIV-positive patients on successful HAART: the role of genotype 3.

Seminari E, Tinelli C, Ravasi G, Ripamonti D, Ladisa N, Marino N, Sighinolfi L, Mondello P, Migliorino M, Carosi G, Maserati R; MASTER Cohort. Seminari E, et al. Among authors: tinelli c. Curr HIV Res. 2010 Apr;8(3):186-93. doi: 10.2174/157016210791111070. Curr HIV Res. 2010. PMID: 20163342

3

Response to antiretroviral treatment after failure of NNRTI plus NRTIs-based therapy. Data from the ARCA collaborative group.

Seminari E, De Silvestri A, Meini G, Callegaro A, Boeri E, Punzi G, Gianotti N, Bruzzone B, Tinelli C, Grossi P. Seminari E, et al. Among authors: tinelli c. Curr HIV Res. 2012 Jun;10(4):334-40. doi: 10.2174/157016212800792469. Curr HIV Res. 2012. PMID: 22591356

4

Effect of highly active antiretroviral therapy (HAART) and hepatitis C Co-infection on hyperlipidemia in HIV-infected patients: a retrospective longitudinal study.

Patroni A, Torti C, Tomasoni L, Quiros Roldan E, Bertelli D, Puoti M, Cadeo GP, Sleiman I, Tinelli C, Carosi G, Castelli F. Patroni A, et al. Among authors: tinelli c. HIV Clin Trials. 2002 Nov-Dec;3(6):451-61. doi: 10.1310/w024-qc4t-nxu0-tkyt. HIV Clin Trials. 2002. PMID: 12501128

5

Incidence and risk factors for liver enzyme elevation during highly active antiretroviral therapy in HIV-HCV co-infected patients: results from the Italian EPOKA-MASTER Cohort.

Torti C, Lapadula G, Casari S, Puoti M, Nelson M, Quiros-Roldan E, Bella D, Pastore G, Ladisa N, Minoli L, Sotgiu G, Mazzotta F, Lo Caputo S, Di Perri G, Filice G, Tinelli C, Carosi G; EPOKA-MASTER Study Group. Torti C, et al. Among authors: tinelli c. BMC Infect Dis. 2005 Jul 14;5:58. doi: 10.1186/1471-2334-5-58. BMC Infect Dis. 2005. PMID: 16018804 Free PMC article.

6

Influence of hepatitis C genotypes on lipid levels in HIV-positive patients during highly active antiretroviral therapy.

Lapadula G, Torti C, Paraninfo G, Castelnuovo F, Uccelli MC, Costarelli S, Ladisa N, Maserati R, Di Pietro M, De Silvestri A, Tinelli C, Puoti M, Carosi G; EPOKa-A Study Group of the MASTER Cohort. Lapadula G, et al. Among authors: tinelli c. Antivir Ther. 2006;11(4):521-7. Antivir Ther. 2006. PMID: 16856626 Clinical Trial.

7

Efavirenz, nelfinavir, and stavudine rescue combination therapy in HIV-1-positive patients heavily pretreated with nucleoside analogues and protease inhibitors.

Seminari E, Maggiolo F, Villani P, Suter F, Pan A, Regazzi MB, Paolucci S, Baldanti F, Tinelli C, Maserati R. Seminari E, et al. Among authors: tinelli c. J Acquir Immune Defic Syndr. 1999 Dec 15;22(5):453-60. doi: 10.1097/00126334-199912150-00005. J Acquir Immune Defic Syndr. 1999. PMID: 10961606 Clinical Trial.

8

Antiviral potency of HAART regimens and clinical success are not strictly coupled in real life conditions: evidence from the MASTER-1 study.

Carosi G, Castelli F, Suter F, Maggiolo F, Orani AM, Pan A, Andreoni M, Vigevani GM, Maserati R, Mazzotta F, Tinelli C; MATER Study Group. Carosi G, et al. Among authors: tinelli c. HIV Clin Trials. 2001 Sep-Oct;2(5):399-407. doi: 10.1310/5xcl-5xe9-jafk-xk7y. HIV Clin Trials. 2001. PMID: 11673814 Clinical Trial.

9

Assessment of atherosclerosis using carotid ultrasonography in a cohort of HIV-positive patients treated with protease inhibitors.

Seminari E, Pan A, Voltini G, Carnevale G, Maserati R, Minoli L, Meneghetti G, Tinelli C, Testa S. Seminari E, et al. Among authors: tinelli c. Atherosclerosis. 2002 Jun;162(2):433-8. doi: 10.1016/s0021-9150(01)00736-5. Atherosclerosis. 2002. PMID: 11996964

10

Predictors of long-term immunological outcome in rebounding patients on protease inhibitor-based HAART after initial successful virologic suppression: implications for timing to switch.

Tomasoni LR, Patroni A, Torti C, Paraninfo G, Gargiulo F, Quiros-Roldan E, Uccelli MC, Airò P, Tinelli C, Carosi G, Castelli F; Brescia-MASTER Study Group. Tomasoni LR, et al. Among authors: tinelli c. HIV Clin Trials. 2003 Sep-Oct;4(5):311-23. doi: 10.1310/FGMF-Y0LY-DMX8-371V. HIV Clin Trials. 2003. PMID: 14583847

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

439 results

Search Page

Filters